With our clinical-scale biologics manufacturing facility offering state-of-the-art production capabilities in San Antonio, Texas, Scorpion Biological Services is executing on a vision to construct a world-class commercial manufacturing facility in Manhattan, Kansas, delivering superior flexible production capabilities through a combination of single-use and stainless steel bioreactors.
The new facility will house independent suites for mammalian and microbial production. Using American-based equipment, we plan to install Single Use bioreactors and stainless steel production tanks in four production phases. Scorpion will offer a total cGMP capacity of approximately 144,000 liters and will be an unrivaled choice to bring your clinical products to patients who need them.
